MedTrace Logo

The Sarcoma Biology and Outcome Project

NCT04758325 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-03-25

No results posted yet for this study

Summary

SarcBOP - An interdisciplinary and translational registry

SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not be limited to specific questions or patient groups, but instead will build a comprehensive database including clinical, pathologic, and radiologic information, multi-layered molecular data, and patient-reported outcomes, combined with a dedicated biobank for tissue samples and liquid biopsies. As the study integrates seamlessly with the clinical activities of the Heidelberg Sarcoma Center, the Molecular Diagnostics Program of NCT Heidelberg, including the NCT/DKTK MASTER Program, and with the NCT Trial Center, including the PMO Clinical Trials Program, SarcBOP will generate a comprehensive and continuously growing resource for clinicians, researchers, and, finally, patients.

Conditions

  • Sarcoma
  • Malignant Mesenchymoma
  • Sarcoma of Bone and Connective Tissue

Sponsors & Collaborators

  • Prof. Dr. Richard F Schlenk

    lead OTHER

Principal Investigators

  • Richard F. Schlenk, Prof.Dr.med · National Center for Tumour Disease

  • Christoph E. Heilig, Dr. med. · National Center for Tumour Disease

  • Stefan Fröhling, Prof. Dr. · National Center for Tumour Disease

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-23
Primary Completion
2030-07-31
Completion
2032-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04758325 on ClinicalTrials.gov